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1. Introduction 
The proton-translocating NADH dehydrogenase of 
bovine heart mitochondria has been isolated in sub- 
stantially unmodified form as complex I or the 
NADH-ubiquinone oxidoreductase complex [ 11. The 
isolated enzyme is a lipoprotein consisting of at least 
26 different polypeptides [2] which bind a molecule 
of FMN and at least 5 iron-sulphur centres [3], 4 of 
which have been purified or partially purified [4]. 
Studies on the organisation of the constituent poly 
peptides both in the isolated enzyme and in the 
membrane have been carried out using hydrophilic 
probes such as diazobenzenesulphonate (DABS) [5] 
and the hydrophobic probe, iodonaphthylazide (INA) 
[6]. Objections to the use of INA have been raised 
[ 71 because of the rather polar nature and long life- 
time of the photogenerated nitrene. Thus, it is pos- 
sible that INA preferentially labels proteins at the 
membrane surface rather than those embedded in the 
hydrophobic region of the membrane although this 
may, in fact, not occur [8]. A potentially better 
membrane probe is a chemically reactive phospho- 
lipid analogue. Here, we have used a phosphatidyl- 
choline with 12-amino-N-(2-nitro-4-azidophenyl) 
dodecanoic acid in the 2 position [9] to photolabel 
isolated complex I. 
2. Materials and methods 
Complex I was prepared as in [lo]. Lipid-deple- 
tion and lipid-supplementation of the enzyme were as 
in [l l] and [6], respectively. [3H]Arylazidophospha- 
tidylcholine (AAPC) was synthesised as in [ 121 with 
a specific radioactivity of 7.5 Ci/mmol. An ethanolic 
solution of AAPC was added to complex I(10 mg/ml 
0.67 M sucrose/50 mM Tris-HCl (pH 8.0)) to a final 
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concentration of 1% of the total phospholipid 
(-2 mol AAF’C/mol enzyme). The final ethanol con- 
centration was <2% (v/v). After 10 min at O”C, the 
sample was diluted S-fold with sucrose-Tris buffer 
and either photolysed directly or photolysed after 
overnight dialysis against 100 vol. of the same buffer. 
Complex I as prepared is soluble because of residual 
cholate. Incorporation of AAPC was therefore due to 
cholate-mediated fusion between complex I/lipid/ 
cholate micelles and AAPC/cholate micelles followed 
by removal of detergent either by dialysis or dilution. 
Photolysis and determination of protein-bound radio- 
activity were carried out as in [6] except that samples 
were illuminated in plastic cells. Gel electrophoresis 
was conducted in 13-16.5% (w/v) acrylamide gra- 
dient gels using the Laemmli [ 131 buffer system or in 
12.5% (w/v) acrylamide cylindrical gels using the 
Weber and Osborn system [ 141. Radioactivity in gels 
was determined as in [6] or by fluorography using 
EnjHance as the scintillant. Molecular masses of con- 
stituent polypeptides were determined by reference 
to M, standards from BDH Chemicals, Poole. 
3. Results and discussion 
Under our conditions, incorporation of radioactiv- 
ity into protein reached 50% of maximum after 30 s 
illumination. The time course and extent of labelling 
was the same whether the sample had been dialysed 
or diluted before illumination. A standard illumina- 
tion period of 2 min was chosen. Over this period 
there was no loss of hADH-ubiquinone oxidoreduc- 
tase activity. Fig. 1 shows the distribution of radio- 
activity between complex I polypeptides after photo- 
labelling in the absence (b) or presence (c) of SDS. 
The labelling of the intact enzyme is quite selective, 
being mainly confined to low M, polypeptides. In 
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Fig. 1. Labelling of complex I and SDS-treated complex I by 
AAPC. Complex I was labelled wth AAPC in the absence and 
presence of 2% (w/v) SDS. Samples were precipitated by 
addition of cold, absolute ethanol and analysed by etectro- 
phoresls according to Weber and &born [ 14 J. (a) Densitom- 
eter profiie uf complex I ge1; tb) ~~d~o~~ctivity incorporated 
into complex I: (cf ~~dloactivity iricorpor~ted Into SDS- 
treated complex 1. 
contrast, SDS-treated enzyme was labelled in al1 poly- 
peptides to approximately the same extent. Presum- 
ably, AAPC can associate equally well with all SDS- 
protein complexes. The incorporation of label into 
protein shown in fig. 1 (b) was -8% of that added to 
the enzyme. Better resolution was obtained using 
gradient gels and fluorography as shown in fig2 
After photolabelii~l~, complex I (D) was resolved with 
the chaotropic agent, NaC104, and the iron-protein 
(A) and flavoprotein jB) fra~ents were isolated 
12.1 S]. The latter consists of3 polypeptides [ 141 and 
catalyses NADIl oxidation by a variety of electron 
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Fig.2 Labelling of complex I and subfracttonr by AAPC. 
Complex I labelled s&h AAPC was resotvcd with NaClU, and 
fractionated with ammonium sulphatc [ 15 1. Samples were 
analysed by electrophoresis on gradient gels and tluorop- 
raphy. (A) ‘Iron-protem’ fraction from 45 ~g of complex I: 
(B) ‘flavoprotein’ fraction from 90 fig complex I: (C) insolu- 
ble residue from 45 g complex I; (D) complex I (45 ~g pro- 
tein): (E) complex I (45 ,q protein) treated wtth SDS before 
labelling. (Left) stained gel; (right) fiuorograph. &fr values 
(X 10.3) of the ‘iron-protent’ subumts and of the major 
lab&led polypeptides are given for reference. 
acceptors [ 1 s]. The 2 larger subunits are iron-sulphur 
proteins [4]. The ‘iron-protein’ fraction contains at 
least 2 iron-sulp~lur centres [4] and contains several 
polypeptides as well as small amounts of the ‘flavo- 
protein’ fraction. Our M, values of the smaller com- 
plex I polypeptides in [ 2,171 appear to be too high 
(e.g.. [lb]> and we have redetermined them using the 
gradient gel system. Our Mr values for the ‘flavopro- 
tein’ fraction subunits are now in good agreement 
with [lh] and the revised M, values of the ‘iron- 
protein’ subunits are 75 000.49 000.30 000, I8 000, 
15 000 and 13 000 as showrl m fig.?. Very little 
radioactivIty was found m any polypept~d~s of the 
‘iron-protein’ or ‘fiavoprotein’ fragments (fig.2). 
This was confirmed using cylindrical gels and dctec- 
tion of radioactivity in gel slices by scintillation 
counting. The only polypeptides to show any label” 
ling were the 49 000 and 15 000 M, polypeptides of 
the ‘iron--protein’ fraction and these only to a very 
small extent. Therefore. in agreement with our con- 
clusions from INA labelfing, the ‘iron-protein’ and 
‘Qavoprotein’ fragnle~its have little if any contact 
with the membrane phospholipid. The insoIuble resi- 
due from Gabon-resolved complex I (C) probably 
contains only one of the 5 or 5 iron-sulphur centres 
of complex 1, but comprises 70% of the original com- 
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plex I protein (41. The heavy labelling of several poly 
peptides of this fraction indicates extensive contact 
with the melnbrar~e phospi~olipid. The most heavily 
labelled polypeptides, of Mr 39 000, 20 000, 15 000 
to 16 000, 13 000 and below, are the same as those 
tabelled by INA. taking into account the superior res- 
olution of the gel system of fig.?,. However there were 
differences in the relative degrees of labelling. For 
example, the 39 000 Mr polypeptide was labelled rel- 
atively more heavily by AAPC while the opposite was 
true of the 15 000 Mr polypeptides @4, = 18 000 in 
[6]). Since the chemicaliy reactive group is very simi- 
lar in both AAPC and INA. these differences may be 
ascribed to different locations of the 2 probes in the 
membrane. The reactive group of AAPC is presum- 
ably located in the middle of the bilayer while INA 
may be less constrained and could label proteins in a 
range of depths in the membrane. Thus, the 39 000 Mr 
polypeptlde may be in contact with the membrane 
phospholipid only near the centre of the membrane. 
In support of this idea, the 39 000 Mr polypeptide is 
inaccessible to hydrophilic labels when the enzyme is 
in the mitochondrial membrane 251. 
The INA-labelling profile of lipid-depleted com- 
plex I showed several differences compared with the 
undepleted enzyme [6]. These differences were also 
seen using AAPC as the label (fig.3). Thus, polypep- 
tides of Mr 49 000,42 000,17 000, 13 000, 10 000, 
7000 and 5000 showed extensive increase in labelling 
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Fig.3 Effects of lipid-depletion or lipid-supplementation on 
AAPC labelling of complex I. Sample analysis and data pre- 
sensation were as in fig.3. (A) Lipiddepleted complex I 
(60 ng protein): (B) native complex I (45 pg protein); (C) 
~pId-supplemented complex I (4.5 ng protein). Mr values 
(X 10y3) of some polypeptides showmg changes tn extent of 
labelling are given for reference. 
(A). However, increasing the lipid content of the 
complex I caused decreases in the labelling of some 
polypeptides, for example, those of Mr 39 000 and 
1.5 000 (C). As discussed in [6], these differences may 
be a result of conformational changes in the enzyme, 
particularly on depletion of lipids, or they be due to 
non-random distribution of different phospholipids, 
for example, cardiolipin and phospllatidylcholine. We 
cannot yet distinguish between these possibilities. 
These results confirm those obtained with INA 
[6] and support the conclusion that the flavin and 
most of the iron-sulphur proteins of complex 1 are 
prevented from contact with the membrane phospho- 
lipid by a shell of small hydrophobic proteins. 
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